![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Meiji Seika Pharma Co., Ltd. Tokyo Jp, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Cyanocobalamin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2004-293 - Rev 01
This Chemical Type CEP, issued on May 26, 2011, remains in force until May 26, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 547 associated with this CEP further emphasizes